Zai Lab (ZLAB) financial statements

Healthcare · Biotechnology · Market cap $2.6B

Zai Lab reported revenue of $457M in fiscal 2025, up 221.4% a year over 7 years.

Net income was -$176M.

Free cash flow was -$159M.

The diluted share count rose 11504% over the period (dilution).

Revenue and free cash flow

Fiscal years, $ billions.

-1-0.500.52016201720182019202020212022202320242025RevenueFree cash flow
Embed this chart

Free to use in articles and newsletters with the source line. Paste this HTML:

Income statement

Fiscal years, from Zai Lab's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Revenue——$129,000$13M$49M$144M$213M$267M$398M$457M
Cost of revenue——$43,000$4M$17M$52M$74M$96M$147M$191M
Gross profit——$85,862$9M$32M$92M$139M$171M$250M$267M
Research and development$32M$39M$120M$142M$223M$573M$286M$266M$235M$221M
Selling, general and admin$6M$12M$22M$70M$111M$219M$259M$282M$299M$278M
Operating income-$39M-$51M-$142M-$203M-$302M-$700M-$404M-$367M-$282M-$229M
Interest expense——$40,000$293,000$181,000$0$0$0$2M$5M
Pre-tax income-$38M-$50M-$138M-$194M-$268M-$703M-$443M-$335M-$257M-$178M
Income tax—$0$0$0$0$0$0$0$0-$3M
Net income-$38M-$50M-$139M-$195M-$269M-$704M-$443M-$335M-$257M-$176M
EPS (diluted)-$3.97-$2.32-$2.64-$3.03-$0.35-$0.76-$0.46-$0.35-$0.26-$0.16
Diluted shares9M22M53M64M777M930M958M966M989M1.10B
Gross margin——66.6%71.1%65.8%63.7%65.2%64.1%63.0%58.3%
Operating margin——-109897.7%-1564.9%-616.4%-485.8%-190.1%-137.4%-71.0%-50.2%
Net margin——-107810.1%-1502.3%-549.3%-488.9%-208.4%-125.5%-64.7%-38.4%

Balance sheet

Fiscal years, from Zai Lab's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Cash and short-term investments$84M$230M$263M$276M$1.2B$1.4B$1.0B$806M$780M$690M
Receivables——$90,000$4M$5M$47M$40M$59M$85M$106M
Inventory——$4,000$6M$13M$19M$32M$45M$40M$75M
Total current assets$84M$231M$269M$292M$1.2B$1.5B$1.1B$940M$1.1B$1.0B
Property, plant and equipment$1M$12M$20M$21M$29M$43M$58M$54M$48M$47M
Total assets$89M$250M$302M$355M$1.3B$1.6B$1.2B$1.0B$1.2B$1.2B
Total current liabilities$5M$12M$49M$47M$98M$193M$140M$203M$299M$416M
Total liabilities$6M$14M$51M$60M$128M$230M$175M$240M$345M$457M
Shareholders' equity-$52M$235M$251M$295M$1.2B$1.4B$1.0B$796M$841M$716M
Net debt-$84M-$230M-$63M-$76M-$442M-$964M-$1.0B-$790M-$450M-$680M

Cash flow

Fiscal years, from Zai Lab's 10-K filings with the SEC.

Fiscal year2016201720182019202020212022202320242025
Operating cash flow-$32M-$32M-$98M-$191M-$216M-$549M-$368M-$198M-$215M-$151M
Capital spending$2M$9M$10M$6M$10M$18M$25M$7M$6M$8M
Free cash flow-$34M-$41M-$108M-$197M-$226M-$568M-$392M-$205M-$221M-$159M
Stock-based compensation$5M$10M$12M$20M$25M$41M$61M$80M$71M$66M
Free cash flow margin——-83374.4%-1517.5%-462.0%-393.8%-184.4%-77.0%-55.5%-34.8%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for ZLAB.
Open ZLAB in Investingly

Questions

What was Zai Lab's revenue in 2025?

$457M in fiscal 2025, from its 10-K filing.

How much free cash flow does Zai Lab generate?

-$159M in fiscal 2025 (operating cash flow minus capital spending).

From Zai Lab's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.